Quantcast Alexza 1Q Loss Widens On Increased Development Costs - Congoo
 
 
Log In
Alexza 1Q loss widens on increased development costs
Have an interest in this Story?
Sign Up for Real-Time email updates
CNBC  | May 12, 2008

MOUNTAIN VIEW, Calif. - Drug developer Alexza Pharmaceuticals Inc. said Monday that its first-quarter loss widened on increased research and development spending. The company lost $14.6 million, or 47 cents per share, compared with $10.9 million, or 46 cents per share, in the year-ago period. Alexza...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Jaime Neyra Morales Jaime Neyra Morales
Relationship Manager, Commercial Banking
Banking
THENNY MEJIA THENNY MEJIA
Sr. Vice President
Healthcare Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.